Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/13/2025

Switching from Quetiapine to Aripiprazole for Catatonic Symptoms

Rationale for the Switch

  • The American Psychiatric Association recommends aripiprazole as a treatment option for catatonia due to its efficacy and lower risk of extrapyramidal symptoms compared to typical antipsychotics 1, 2

Switching Strategy

  • The National Institute of Mental Health suggests starting with 5 mg of aripiprazole daily and titrating as needed, with consideration for higher doses in severe cases and reduced doses in older patients or those with poor CYP2D6 metabolism 1, 2
  • The American Academy of Psychiatry and the Law recommends a gradual cross-titration approach when switching from quetiapine to aripiprazole, informed by the half-life and receptor profile of each medication 3, 4, 5

Critical Considerations

  • The World Health Organization advises monitoring for cytochrome P450 2D6 and 3A4 drug interactions, as these can affect aripiprazole levels, and watching for potential side effects such as headache, agitation, and dizziness 1, 2
  • The American Family Physician recommends avoiding the use of typical antipsychotics, such as haloperidol, due to the higher risk of extrapyramidal symptoms, and avoiding combination with high-dose benzodiazepines initially due to the risk of oversedation 6, 7, 8